Showing 1 - 20 results of 52 for search 'Robert Flisiak', query time: 0.08s
Refine Results
-
1
Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism by Piotr Rzymski, Bartłomiej Perek, Robert Flisiak
Published 2021-05-01
Article -
2
Ways to Eliminate Viral Hepatitis as a Global Health Threat by Robert Flisiak, Dorota Zarębska-Michaluk, Marta Flisiak-Jackiewicz
Published 2022-07-01
Article -
3
The Role of Th17 Response in COVID-19 by Diana Martonik, Anna Parfieniuk-Kowerda, Magdalena Rogalska, Robert Flisiak
Published 2021-06-01
Article -
4
Updates in Management of SARS-CoV-2 Infection by Robert Flisiak, Dorota Zarębska-Michaluk, Marta Flisiak-Jackiewicz, Piotr Rzymski
Published 2022-07-01
Article -
5
-
6
-
7
-
8
-
9
Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients by Kamil Grubczak, Anna Grzeszczuk, Monika Groth, Anna Hryniewicz, Anna Kretowska-Grunwald, Robert Flisiak, Marcin Moniuszko
Published 2021-07-01
Article -
10
-
11
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C. by Robert Flisiak, Mitchell Shiffman, Juan Arenas, Hugo Cheinquer, Igor Nikitin, Yuping Dong, Khurram Rana, Subasree Srinivasan
Published 2016-01-01
Article -
12
Rotational Thromboelastometry (ROTEM<sup>®</sup>) in Relation to Inflammatory Biomarkers and Clinical Outcome in COVID-19 Patients by Pawel Rogalski, Magdalena Rogalska, Diana Martonik, Malgorzata Rusak, Joanna Pawlus, Joanna Chociej-Stypulkowska, Milena Dabrowska, Robert Flisiak
Published 2023-06-01
Article -
13
A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. by Tarik Asselah, Alex J Thompson, Robert Flisiak, Manuel Romero-Gomez, Diethelm Messinger, Georgios Bakalos, Mitchell L Shiffman
Published 2016-01-01
Article -
14
-
15
-
16
Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C—Results of a Multicenter EpiTer-2 Study by Malgorzata Pawlowska, Krystyna Dobrowolska, Justyna Moppert, Maria Pokorska-Śpiewak, Mariola Purzynska, Magdalena Marczynska, Dorota Zarebska-Michaluk, Robert Flisiak
Published 2023-11-01
Article -
17
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasi... by Robert Flisiak, Krasimir Antonov, Pavel Drastich, Peter Jarcuska, Marina Maevskaya, Mihály Makara, Željko Puljiz, Borut Štabuc, Anca Trifan
Published 2021-11-01
Article -
18
Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine by Piotr Rzymski, Monika Pazgan-Simon, Krzysztof Simon, Tadeusz Łapiński, Dorota Zarębska-Michaluk, Barbara Szczepańska, Michał Chojnicki, Iwona Mozer-Lisewska, Robert Flisiak
Published 2021-07-01
Article -
19
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review by Piotr Rzymski, Maria Pokorska-Śpiewak, Teresa Jackowska, Ernest Kuchar, Aneta Nitsch-Osuch, Małgorzata Pawłowska, Mateusz Babicki, Jerzy Jaroszewicz, Leszek Szenborn, Jacek Wysocki, Robert Flisiak
Published 2023-09-01
Article -
20
Pneumococcal vaccination among adults – updated Polish recommendations by ERNEST KUCHAR, ADAM ANTCZAK, ANNA SKOCZYŃSKA, ANDRZEJ FAL, JACEK WYSOCKI, JOLANTA WALUSIAK-SKORUPA, MAŁGORZATA CZAJKOWSKA-MALINOWSKA, AGNIESZKA MASTALERZ-MIGAS, ROBERT FLISIAK, ANETA NITSCH-OSUCH
Published 2022-10-01
Article